Unlock stock picks and a broker-level newsfeed that powers Wall Street.
HKSE - Delayed Quote HKD

Grand Brilliance Group Holdings Limited (8372.HK)

Compare
0.111
-0.003
(-2.63%)
At close: April 1 at 11:11:40 AM GMT+8
Loading Chart for 8372.HK
  • Previous Close 0.114
  • Open 0.118
  • Bid 0.105 x --
  • Ask 0.111 x --
  • Day's Range 0.103 - 0.118
  • 52 Week Range 0.081 - 0.119
  • Volume 230,000
  • Avg. Volume 134,262
  • Market Cap (intraday) 88.8M
  • Beta (5Y Monthly) -0.06
  • PE Ratio (TTM) 11.10
  • EPS (TTM) 0.010
  • Earnings Date Feb 10, 2025 - Feb 11, 2025
  • Forward Dividend & Yield 0.00 (2.19%)
  • Ex-Dividend Date Jul 15, 2024
  • 1y Target Est --

Grand Brilliance Group Holdings Limited, an investment holding company, engages in supplying of medical devices in Hong Kong. The company offers medical consumables; medical instruments; and medical equipment, as well as develops healthcare products. It also provides medical device solutions, such as market trend analysis, sourcing of medical devices, after-sale services, technical support and training services, medical devices leasing services, and quality assurance services; and maintenance and after sale services, as well as holds trademarks. It sells its products to government department, hospitals, elderly home, universities, non-private organization, and individual end users. Grand Brilliance Group Holdings Limited was founded in 1997 and is based in Tsuen Wan, Hong Kong.

www.grandbrilliancegroup.com

50

Full Time Employees

March 31

Fiscal Year Ends

Recent News: 8372.HK

View More

Performance Overview: 8372.HK

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

8372.HK
24.72%
HANG SENG INDEX (^HSI)
13.91%

1-Year Return

8372.HK
13.91%
HANG SENG INDEX (^HSI)
36.62%

3-Year Return

8372.HK
69.22%
HANG SENG INDEX (^HSI)
3.68%

5-Year Return

8372.HK
96.23%
HANG SENG INDEX (^HSI)
1.66%

Compare To: 8372.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 8372.HK

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    91.20M

  • Enterprise Value

    36.83M

  • Trailing P/E

    10.96

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.11

  • Price/Book (mrq)

    0.87

  • Enterprise Value/Revenue

    0.45

  • Enterprise Value/EBITDA

    4.16

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.27%

  • Return on Assets (ttm)

    2.56%

  • Return on Equity (ttm)

    8.19%

  • Revenue (ttm)

    82.29M

  • Net Income Avi to Common (ttm)

    8.45M

  • Diluted EPS (ttm)

    0.010

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    66.48M

  • Total Debt/Equity (mrq)

    4.01%

  • Levered Free Cash Flow (ttm)

    10.6M

Research Analysis: 8372.HK

View More

Company Insights: 8372.HK

Research Reports: 8372.HK

View More

People Also Watch